Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer

NCT04632459 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center